Bayer announced on Friday that it will pay about $145 million to acquire Teva Pharmaceuticals' U.S. animal health unit in a deal expected to close next year. More
-
-
Sponsored By:
-
Sponsored By:
TEVA
FDA Approves Second Multiple Sclerosis Pill
The FDA has granted approval for Sanofi's multiple sclerosis drug, Aubagio, the second pill now available to treat the disease. More
Israel: Beyond the Risk, Opportunities Beckon
When you think of Israel, you probably think of conflict. But it has a strong economy and growing companies if you're willing to be a bit daring. More
HCA Hospitals Questioned About ‘Unnecessary’ Heart Surgeries
The nation's largest for-profit hospital chain is reportedly under scrutiny for cardiology services at about 10 of its 163 hospitals. More
Uh-Oh, Merck: FDA Approves Cheaper Versions of Singulair
The FDA granted marketing approval for generic versions of Merck's asthma drug Singulair to ten manufacturers on Friday. More
4 Pharmaceutical Stocks to Sell Now
For the current week, the overall ratings of four Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Retail Results Spoil the Day — Monday’s IP Market Recap
A disappointing retail report and mixed results for Citigroup's second quarter weighed on markets Monday, though M&A news sparked life into pharma. More
